טוען...
α(1)-Antitrypsin deficiency · 6: New and emerging treatments for α(1)-antitrypsin deficiency
Alpha-1-antitrypsin (AAT) deficiency is a genetic condition that increases the risk of developing lung and liver disease, as well as other associated conditions. Most treatment of affected individuals is not specifically directed at AAT deficiency but focuses on the resultant disease state. The only...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Group
2004
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1746849/ https://ncbi.nlm.nih.gov/pubmed/15454659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thx.2003.006551 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|